PDN-32195-00131
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 928 / CA
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 1 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-10
- 2021-02-11
- 2021-02-18
-
2021-02-25
Dose 2 — Pfizer-BioNTech
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-11
- 2021-03-18
- 2021-03-26
- 2021-04-01
-
2021-04-08
Survey response — day 42, dose 2MedDRA: Ear discomfort, Headache, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold or flu symptoms. Headaches, ear pressure, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech |
Free text
Release 7 — day 42, dose 2
Symptoms: Cold or flu symptoms. Headaches, ear pressure, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ear discomfort | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release